R 299.9830 Hazardous waste pharmaceuticals and hazardous waste ENDS; residues of hazardous waste pharmaceuticals or hazardous waste ENDS in empty containers.

Rule 830. (1) A stock bottle, dispensing bottle, vial, or ampule of less than or equal to 1 liter or 10,000 pills; or a unit-dose container such as a unit-dose packet, cup, wrapper, blister pack, or delivery device is considered empty and the residues are not regulated as hazardous waste if the pharmaceuticals have been removed from the container using the practices commonly employed to remove materials from that type of container. (2) Nicotine e-liquid vials packaged for retail sale in ENDS and less than or equal to 1 liter are considered empty and the residues are not regulated as hazardous waste if the liquid has been removed by pouring out the contents. (3) A syringe is considered empty, and the residues are not regulated as hazardous waste if the contents have been removed by fully depressing the plunger of the syringe. If a syringe is not empty, the syringe must be placed with its remaining hazardous waste pharmaceuticals into a container that is managed and disposed of as a non-creditable hazardous waste pharmaceutical under R 299.9824 to R 299.9833 and any applicable federal, state, and local requirements for sharps containers and medical waste. (4) An intravenous bag is considered empty, and the residues are not regulated as hazardous waste if the pharmaceuticals in the bag have been fully administered to a patient. If an intravenous bag is not empty, the bag must be placed with its remaining hazardous waste pharmaceuticals into a container that is managed and disposed of as a non-creditable hazardous waste pharmaceutical R 299.9824 to R 299.9833, unless the bag held non-acute hazardous waste pharmaceuticals and is empty as defined in R 299.9207. (5) Hazardous waste pharmaceuticals remaining in all other types of unused, partially administered, or fully administered containers must be managed as non-creditable hazardous waste pharmaceuticals under R 299.9824 to R 299.9833, unless the container held non-acute hazardous waste pharmaceuticals and is empty as defined in R 299.9207. This includes, but is not limited to, residues in inhalers, aerosol cans, nebulizers, tubes of ointments, gels, or creams. (6) Hazardous waste ENDS, including attached or attachable cartridges, pods, or tanks, that are unused, partially used, or fully used must be managed as hazardous waste, except empty vials described in subrule (1) or (2) of this rule.